ADVERTISEMENT

India US Trade Deal Live: Trump Threatens 200% Tariffs On Pharma, Announces 50% Levy On Copper

India-US Trade Deal Live: Will give about a year and a half for tariffs on pharmaceuticals, stated US President Trump in the presser, threatening a 200% levy.

<div class="paragraphs"><p>India and the US have been locked in weeks-long deliberations to hammer out a trade deal. (Image: NDTV Profit)</p></div>
India and the US have been locked in weeks-long deliberations to hammer out a trade deal. (Image: NDTV Profit)
ADVERTISEMENT
Welcome to NDTV Profit's coverage of US President Donald Trump's movements on the global trade front, after he announced fresh tariffs on 14 countries ranging from South Korea to Japan to the tune of 25% - 40%.
LIVE FEED
Latest First
  • Oldest First

US Trade Deal Live: Pharma Stocks To Be In Focus After Tariff Threats

Shares of companies like Dr. Reddy's Laboratories Ltd., Sun Pharmaceuticals Industries Ltd., Cipla Ltd., and more will be in focus on Wednesday after US President Donald Trump threatened to slap 200% tariffs on pharmaceutical products.

Read the whole story here.


US Trade Deal Live: Trump's Latest Levies

Dive deeper into the levies imposed on copper and the potential pharma tariffs of 200% here.


US Trade Deal Live: Trump Threatens 200% Tariffs On Pharma, Announces 50% Levy On Copper

Trump announced a 50% levy on copper in the presser following the cabinet meet.

Will give about a year and a half for tariffs on pharma, said Trump, adding that USA could look at 200% tariffs for pharma products.


US Trade Deal Live: Tariffs Could've Been Much Higher, Says Trump

The USA could have been much harsher, and could have gone much higher with tariffs, stated Trump.

Source: Cabinet meet presser


US Trade Deal Live: India, Other BRICS Countries To See Added 10% Levy

All members of BRICS will be charged 10% tariffs, including India, as BRICS was set up to hurt America and destroy the dollar, declared Trump in the presser.

Source: Cabinet meet presser















OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit